Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:approves |
gptkb:2000
gptkb:FDA |
| gptkbp:available_in |
Various strengths
|
| gptkbp:available_on |
gptkb:tablet
|
| gptkbp:body_shape |
Oval
|
| gptkbp:brand |
gptkb:Claritin
|
| gptkbp:clinical_trial |
Studies on long-term use
Studies on drug interactions Studies on efficacy and safety Studies on side effects |
| gptkbp:color |
Blue and white
|
| gptkbp:contains |
gptkb:Loratadine
gptkb:Pseudoephedrine |
| gptkbp:contraindication |
MAO inhibitors
Severe coronary artery disease Severe hypertension |
| gptkbp:dosage_form |
One tablet every 12 hours
|
| gptkbp:formulation |
Extended-release
|
| https://www.w3.org/2000/01/rdf-schema#label |
Claritin-D 12 Hour
|
| gptkbp:ingredients |
gptkb:Loratadine
gptkb:Pseudoephedrine_sulfate |
| gptkbp:interacts_with |
Alcohol
Other antihistamines Blood pressure medications |
| gptkbp:is_recommended_for |
Adults and children 12 years and older
|
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:marketed_as |
gptkb:Canada
gptkb:United_States Other countries |
| gptkbp:packaging |
Blister pack
|
| gptkbp:previous_name |
Loratadine and pseudoephedrine
|
| gptkbp:requires |
Over-the-counter
|
| gptkbp:safety |
Keep out of reach of children
Do not exceed recommended dose Consult a doctor if you have a medical condition Seek medical help in case of overdose |
| gptkbp:shelf_life |
Check packaging for date
|
| gptkbp:side_effect |
gptkb:Insomnia
Drowsiness Dry mouth Nervousness |
| gptkbp:storage |
Store at room temperature
|
| gptkbp:suitable_for |
Children under 12 years
Pregnant women without doctor consultation Nursing mothers without doctor consultation |
| gptkbp:taste |
Not applicable
|
| gptkbp:used_for |
Allergy relief
Nasal congestion relief |
| gptkbp:bfsParent |
gptkb:Claritin
|
| gptkbp:bfsLayer |
6
|